アラバマ州におけるうつ病の臨床試験
アラバマ州内の拠点で、うつ病に関する15件の研究が参加者を募集しています。
アラバマ州内の都市
公式研究テキスト（英語）
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- University of Alabama at Birmingham - School of Medicine, Birmingham
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07775300A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- UAB Psychiatry and Behavioral Neurology, Birmingham
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/25更新 · NCT06793397RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- University of Alabama at Birmingham, Huntsville Regional Medical Campus, Huntsville
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/08更新 · NCT07076407Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/14更新 · NCT07226232NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06911112Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
被験者募集中健康なボランティア歓迎
10歳〜24歳 · 全性別 · 2026/07/13更新 · NCT05437588A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Center, Huntsville
被験者募集中
18歳以上 · 全性別 · 2026/06/15更新 · NCT03887715Investigating Dynamic Interactions in Distributed Cognitive Control Networks
- University of Alabama at Birmingham, Birmingham
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/29更新 · NCT05927974Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
- University of South Alabama, Mobile
被験者募集中
19歳〜65歳 · 全性別 · 2026/04/06更新 · NCT06467695MicroRNA Correlates of Childhood Maltreatment and Suicidality
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
被験者募集中観察研究健康なボランティア歓迎
18歳〜60歳 · 全性別 · 2026/03/30更新 · NCT04923685Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- University of Alabama Birmingham Hospital, Birmingham
被験者募集中
12歳〜22歳 · 全性別 · 2025/10/30更新 · NCT06232304Digital Intervention for Physical Activity
- Kinesiology Building, Auburn
被験者募集中
19歳〜40歳 · 全性別 · 2025/09/18更新 · NCT07130734Strengthening Health and Insight in New Educators
- University of Alabama, Tuscaloosa
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2025/04/02更新 · NCT06745934ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。